Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Shenzhen Hepalink IPO Creates China’s Wealthiest Couple

publication date: May 5, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shenzhen Hepalink Pharmaceutical Co., Ltd. will stage an IPO on the Shenzhen exchange, raising 5.9 billion RMB ($868 million). The IPO price of 148 RMB ($21.62) set a record as the highest IPO price in China's A-share market. Hepalink is the world’s largest producer of heparin, a blood thinner that is harvested from pigs’ intestines. The event made the founders of the company, a couple named Li Li and Li Tan, the richest couple in China, with a stake in Hepalink that is now worth 40.7 billion RMB ($6 billion).  More details...




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors